Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
MedCap AB (publ)
STO:MCAP
MedCap AB (publ)
STO:MCAP
Price:
552
SEK
-1.25%
Market Closed
Market Cap:
kr8.3B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
MedCap AB (publ)
STO:MCAP
|
SE |
|
A
|
Apex Critical Metals Corp
OTC:APXCF
|
CA |
|
Toray Industries Inc
TSE:3402
|
JP |
|
BeOne Medicines AG
NASDAQ:ONC
|
CH |
Wall St Price Targets
MCAP Price Forecast
Based on 4 analysts
Based on 4 analysts
+20% Upside
from
kr552
today
MedCap AB (publ) (MCAP)’s 12-month stock price forecast through November 2027 has a consensus target of kr659.94, implying 20% upside. The forecast is based on price targets from 4 Wall Street analysts.
MCAP Analyst Rating
No ratings yet
No ratings yet
MedCap AB (publ) Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MCAP's stock price target?
Price Target
659.94
SEK
659.94
SEK
According to Wall Street analysts, the average 1-year price target for MCAP is 659.94 SEK with a low forecast of 640.34 SEK and a high forecast of 693 SEK.
What is the Revenue forecast for MedCap AB (publ)?
Projected CAGR
12%
12%
Over the last 7 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 12%.
What is the Gross Profit forecast for MedCap AB (publ)?
Projected CAGR
13%
13%
Over the last 7 years, the compound annual growth rate for Gross Profit has been 25%. The projected CAGR for the next 3 years is 13%.
What is the Operating Income forecast for MedCap AB (publ)?
Projected CAGR
17%
17%
Over the last 7 years, the compound annual growth rate for Operating Income has been 33%. The projected CAGR for the next 3 years is 17%.
What is the Pre-Tax Income forecast for MedCap AB (publ)?
Projected CAGR
18%
18%
Over the last 7 years, the compound annual growth rate for Pre-Tax Income has been 33%. The projected CAGR for the next 3 years is 18%.
What is the Net Income forecast for MedCap AB (publ)?
Projected CAGR
18%
18%
Over the last 7 years, the compound annual growth rate for Net Income has been 132%. The projected CAGR for the next 3 years is 18%.
